China Biosimilars Market Size Forecast (2024–2032)

Free

in USD Million

Rising Oncology, Autoimmune, and Chronic Disease to Boost China Biosimilars Market (2024–2032)

Published by MMR Statistics Reserch Team, November 2025

Rapid reforms and expanding biomanufacturing capacity drive accelerated growth in the China Biosimilars Market. The China Biosimilars Market recorded revenue of USD 1,621.45 million in 2024 and is projected to reach USD 5,136.21 million by 2032, reflecting China’s increasing influence in the global biosimilars landscape. Favorable regulatory pathways, broader NRDL reimbursement inclusion, and expanding domestic production capabilities strengthen adoption across oncology, autoimmune, and chronic disease treatments. Strategic investments in R&D, competitive pricing, and enhanced distribution networks contribute to market momentum. As China deepens biologics affordability and innovation capacity, biosimilars play a pivotal role in advancing nationwide therapeutic access.

OTHER STATISTICS ON TOPIC

Biosimilars

More statistics on Biosimilars

Download

Information

Unit

in USD Million

Region

China

Time Period

2024-2032

Source Name

Maximize Market Research Pvt. Ltd

Source Link

http://www.maximizemarketresearch.com

Publisher Name

Maximize Market Research Pvt. Ltd

Publisher Link

http://www.maximizemarketresearch.com

Related reports

Market Research Reports on Biosimilars

Explore published research tied to this statistic's topic. Open the featured edition or jump into another region without leaving the page.

Open featured report

Subscriptions

Stay ahead of Biosimilars with tailored access

Sample free-tier statistics or unlock premium coverage for this topic with team-friendly usage rights.

Discover

Try free-tier statistics before committing to a plan.

Start for Free

Professional

Unlock premium coverage across this topic with analyst support.

Select Plan

Contact our team

Need a bespoke deep-dive on Biosimilars?

Tell us about your KPIs and coverage priorities. We can tailor a briefing, share methodology notes, or build a custom dataset that complements the reports and statistics you are browsing.

Talk with an analyst